期刊文献+

老年慢性阻塞性肺病患者医院肺炎病原菌及耐药性分析 被引量:10

Analysis of bacteria and drug resistance of pathogens for nosocomial pneumonia(NP) with chronic obstructive pulmonary disease(COPD)
下载PDF
导出
摘要 目的探讨老年慢性阻塞性肺病(COPD)患者医院肺炎的常见病原菌类型及对常用抗菌药物的耐药情况。方法收集老年COPD医院肺炎的晨痰或气管切开处深部分泌物进行细菌培养和菌株鉴定,用微量稀释法药敏试验检测16种抗菌药物MIC90。结果分离出病原菌131株,其中革兰阴性杆菌84株(64.1%),铜绿假单胞菌居首位;酵母样真菌41株(31.3%);革兰阳性需氧球菌6株(4.6%)。多种革兰阴性杆菌对大多数抗菌药物的耐药率达30%以上,对亚胺培南的耐药率最低(0~11.1%),但在铜绿假单胞菌中已检出一定比例的中介菌株;对含酶抑制剂抗生素的耐药率低于不含酶抑制剂者。结论革兰阴性杆菌为老年COPD医院肺炎的主要病原菌,以铜绿假单胞菌为首位,对常用抗菌药物耐药率高。 [Objective] To study the bacteria type and drug resistance of pathogens for NP in elderly patients with COPD. [Methods] Sputa or tracheal exudation of NP in elderly patients with COPD were collected to isolate bacteria; The minimum inhibitory concentrations 90(MIC90) of 16 kinds of antibiotic was determined by microdilution method. [Results] 131 strains of bacteria were isolated among those, G^- bacillus were 84 strains (64.1%), pseudomonas aeruginosa was premier; Fungus were 41 strains (31.3%); G^+ coccus were 6 strains (4.6%). The resistant rate to most antibiotic of G^- bacillus was more than 30%, but to imipenem was only 0-11%, some inter mediate bacteria strains have been detected in pseudomonas aeruginosa and its resistant rate to antibiotics with restrainable enzyme was lower than that without restrainable enzyme. [Conclusion] G^- bacillus was main etiologic agent of NP in elderly patients with COPD; pseudomonas aeruginosa was premier and its resistant rate to antibiotics was high.
机构地区 株洲三三一医院
出处 《中国现代医学杂志》 CAS CSCD 北大核心 2006年第7期1083-1085,共3页 China Journal of Modern Medicine
关键词 慢性阻塞性肺病 肺炎 痛原菌 抗菌药物 耐药 COPD puenmonia pathogen antibiotic drug resistance
  • 相关文献

参考文献3

二级参考文献49

  • 1Bourjeily G, Rochester CL. Exercise training in chronic obstructive pulmonary disease[J]. Clin Chest Med, 2000, 21: 763-781.
  • 2Oga T, Nishimura K, Tsukino M, et al. Analysis of the factors related to mortality in chronic obstructive pulmonary disease: role of exercise capacity and health status [J]. Am J Respir Crit Care Med,2003, 167:544-549.
  • 3Gosselink R, Troosters T, Decramer M. Peripheral muscle weakness contributes to exercise limitation in COPD[J]. Am J Respir Crit Care Med, 1996, 153: 976-980.
  • 4Agusti AG, Sauleda J, Miralles C, et al. Skeletal muscle apoptosis and weight loss in chronic obstructive pulmonary disease [J]. Am J Respir Crit Care Med, 2002, 166: 485-489.
  • 5De TroyerA. Effect of hyperinflation on the diaphragm [J]. Eur Respir, 1997, 10: 708-713.
  • 6Montes de Oca M, Rassulo J, Celli BR. Respiratory muscle and cardiopulmonary function during exercise in very severe COPD[J]. Am J Respir Crit Care Med, 1996, 154: 1284-1289.b
  • 7Fujii T, Kurihara N, Fujimoto S, et al. Role of pulmonary vascular disorder in determining exercise capacity in patients with severe chronic obstructive pulmonary disease[J]. Clin Physiol, 1996, 16:521-533.
  • 8Ferrari K, Goti P, Misuri G, et al. Chronic exertional dyspnea and respiratory muscle function in patients with chronic obstructive pulmonary disease[J]. Lung, 1997, 175: 311-319.
  • 9Killian KJ, Leblanc P, Martin DH, et al. Exercise capacity and ventilatory, circulatory, and symptom limitation in patients with chronic airflow limitation[J]. Am Rev Respir Dis, 1992, 146: 935-940.
  • 10Mador MJ, Kufel TJ, Pineda LA, et al. Diaphragmatic fatigue and high-intensity exercise in patients with chronic obstructive pulmonary disease[J]. Am J Respir Crit Care Med, 2000, 161: 118-123.

共引文献5132

同被引文献58

引证文献10

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部